BHB Therapeutics Company

BHB Therapeutics is developing novel approaches to induce a state of ketosis, which may have protective effects against age-related disease.


Investors

Founded Date: 2018
Total Funding: 3000000
Investor Type: For Profit
Employee Number: 11-50
Technology: Other
Last Funding Type: Venture - Series Unknown
Investors Number: 1
Last Funding Date: 2019
Industry: Biotechnology, Pharmaceutical
Headquarters: Douglas, NA - Isle of Man, Isle of Man
Estimated Revenue: Less than $1M